Delisting riskEarnings in 2d
CELU · NASDAQ · Biotechnology

Celularity

Develops placenta-derived cell therapies for longevity and age-related disease.

$1.48
After-hours close−0.09 (−5.63%)
At close$1.57(−25.24%)

Breakdown13F · Form 4

Institutions 7.61%2.20M sharesInsiders 14.63%4.24M sharesOther 77.76%22.51M shares

Shares outstanding 28.95M · Float 18.87M · 65.2% free float

Top shareholders13F · 13D/G · Form 4

HolderShares% outstandingFormFiled
Lim Kok Thay14.14M41.00%13DJul 28, 2025
Philip & Daniele Barach Family Trust5.51M15.80%13DJun 23, 2026
Philp & Daniele Barach Family Trust3.01M9.56%13DApr 3, 2026
Robert J. Hariri · director, officer: Chief Executive Officer2.85M9.86%Form 4Apr 15, 2026
C V Starr & Co Inc764.1K2.64%13FAug 11, 2026

Institutions13F, as of Jun 30, 2026

41 holders · 2.20M shares · 6 new positions · 14 increased · 5 reduced · 4 closed

HolderShares% outstandingChg q/qFiled
C V Starr & Co Inc764.1K2.64%0Aug 11, 2026
Vanguard Capital Management LLC621.1K2.15%0Aug 13, 2026
Geode Capital Management, LLC167.2K0.58%−23.9KAug 12, 2026
Citadel Advisors LLC99.1K0.34%+99.1KAug 14, 2026
Vanguard Fiduciary Trust Co79.9K0.28%0Aug 13, 2026
BlackRock, Inc.76.4K0.26%−51.1KAug 7, 2026
State Street Corp57.8K0.20%0Aug 7, 2026
HRT Financial LP56.6K0.20%+43.8KAug 14, 2026

Beneficial owners13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Lim Kok Thayincl. Dragasac Limited, Resorts World Inc Pte. Ltd. +1 more41.00%14.14M13DJul 28, 2025
Philip & Daniele Barach Family Trustincl. Philip A. Barach, Daniele Barach15.80%5.51M13DJun 23, 2026
Philp & Daniele Barach Family Trustincl. Daniele Barach, Philip A. Barach9.56%3.01M13DApr 3, 2026

InsidersForm 4

InsiderRoleShares% outstandingFiled
Robert J. Hariridirector, officer: Chief Executive Officer2.85M9.86%Apr 15, 2026
Diane L. Parksdirector520.0K1.80%Jan 14, 2026
Peter Diamandisdirector394.2K1.36%Jan 14, 2026
Geoffrey M.D. Lingdirector256.0K0.88%Jan 14, 2026
Vincent LeViendirector153.8K0.53%Jan 14, 2026
John R. Hainesofficer: Senior Exec Vice President30.2K0.10%Apr 15, 2026
David C. Beersofficer: Chief Financial Officer18.2K0.06%Apr 15, 2025
Stephen Brigidoofficer: Pres., Functional Regeneration9.5K0.03%Apr 15, 2026

5 ten-percent owners hold 10.73M shares by Form 4, outside the officers-and-directors figure above · 11 people have not refiled in the last 18 months (735.5K shares), so they are not in the figure above

Latest trades

No open-market trades in the last 12 months.

CongressHouse and Senate disclosures

Not reported.